Implementation and evaluation of pharmacist-led heart failure diagnostic and guideline directed medication therapies clinic.

IF 2.6 4区 医学 Q2 PHARMACOLOGY & PHARMACY International Journal of Clinical Pharmacy Pub Date : 2024-08-27 DOI:10.1007/s11096-024-01790-2
Angharad Thomas, Paul Forsyth, Ciara Griffiths, Rhian Evans, Christine Pope, Teleri Cudd, Jennifer Morgan, Laura Curran, Gethin Hopley, Bernadette Davies, Rachel Smout, Danielle Samuel, Julie Thomas, Paul Smith
{"title":"Implementation and evaluation of pharmacist-led heart failure diagnostic and guideline directed medication therapies clinic.","authors":"Angharad Thomas, Paul Forsyth, Ciara Griffiths, Rhian Evans, Christine Pope, Teleri Cudd, Jennifer Morgan, Laura Curran, Gethin Hopley, Bernadette Davies, Rachel Smout, Danielle Samuel, Julie Thomas, Paul Smith","doi":"10.1007/s11096-024-01790-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Timely diagnosis of heart failure (HF) and rapid optimisation of guideline-directed medication therapy (GDMT) improves patients qualities of life, reducing mortality and morbidity. Previous papers describe the role of pharmacists in medication optimisation, but not in the diagnosis of HF.</p><p><strong>Aim: </strong>To describe the development, implementation, and evaluation of pharmacist-led heart failure clinics with respect to time from referral to diagnosis, time from diagnosis to first review with a specialist, and the proportion receiving optimal GDMT 180 days after diagnosis.</p><p><strong>Setting: </strong>Community outpatient clinics in rural west Wales, United Kingdom.</p><p><strong>Development: </strong>Two experienced non-medical prescribing pharmacists, one of whom had additional diagnostic qualifications in cardiology, delivered the clinic.</p><p><strong>Implementation: </strong>Patients referred with suspected HF were risk-stratified to urgent (within 14 days of referral) or routine (within 42 days) review, based on natriuretic peptide levels. Patients attended the clinic for assessment, including physical examination, electrocardiogram, and echocardiogram. Those with HF with reduced ejection fraction were initiated on drug treatment and referred to the follow-up pharmacist-led GDMT clinic.</p><p><strong>Evaluation: </strong>A sample of 100 patients was evaluated (50 from pre-existing and 50 from new service). Median time from referral to diagnosis reduced from 61 days (IQR 47-115) to 16 days (IQR 10.5-27.5) for urgent and 19 days (IQR 11.5-33) for routine. Median time to first appointment following diagnosis reduced from 54 days (IQR 36-60.5) to 14 days (IQR 9.75-28.75) (p value < 0.0001), and proportion of patients achieving GDMT at 180 days following diagnosis improved from 24 to 86% (p value < 0.0001).</p><p><strong>Conclusion: </strong>This pharmacist HF diagnostic clinic and medication optimisation clinic improved time to diagnosis, time to first specialist review, and proportion of patients' achieving GDMT optimisation in a rural healthcare setting.</p>","PeriodicalId":13828,"journal":{"name":"International Journal of Clinical Pharmacy","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Clinical Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11096-024-01790-2","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Timely diagnosis of heart failure (HF) and rapid optimisation of guideline-directed medication therapy (GDMT) improves patients qualities of life, reducing mortality and morbidity. Previous papers describe the role of pharmacists in medication optimisation, but not in the diagnosis of HF.

Aim: To describe the development, implementation, and evaluation of pharmacist-led heart failure clinics with respect to time from referral to diagnosis, time from diagnosis to first review with a specialist, and the proportion receiving optimal GDMT 180 days after diagnosis.

Setting: Community outpatient clinics in rural west Wales, United Kingdom.

Development: Two experienced non-medical prescribing pharmacists, one of whom had additional diagnostic qualifications in cardiology, delivered the clinic.

Implementation: Patients referred with suspected HF were risk-stratified to urgent (within 14 days of referral) or routine (within 42 days) review, based on natriuretic peptide levels. Patients attended the clinic for assessment, including physical examination, electrocardiogram, and echocardiogram. Those with HF with reduced ejection fraction were initiated on drug treatment and referred to the follow-up pharmacist-led GDMT clinic.

Evaluation: A sample of 100 patients was evaluated (50 from pre-existing and 50 from new service). Median time from referral to diagnosis reduced from 61 days (IQR 47-115) to 16 days (IQR 10.5-27.5) for urgent and 19 days (IQR 11.5-33) for routine. Median time to first appointment following diagnosis reduced from 54 days (IQR 36-60.5) to 14 days (IQR 9.75-28.75) (p value < 0.0001), and proportion of patients achieving GDMT at 180 days following diagnosis improved from 24 to 86% (p value < 0.0001).

Conclusion: This pharmacist HF diagnostic clinic and medication optimisation clinic improved time to diagnosis, time to first specialist review, and proportion of patients' achieving GDMT optimisation in a rural healthcare setting.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
以药剂师为主导的心力衰竭诊断和指南指导药物治疗诊所的实施与评估。
背景:及时诊断心力衰竭(HF)并迅速优化指导性药物治疗(GDMT)可提高患者的生活质量,降低死亡率和发病率。目的:描述以药剂师为主导的心力衰竭诊所的发展、实施和评估情况,包括从转诊到诊断的时间、从诊断到专家首次复查的时间以及诊断后 180 天内接受最佳 GDMT 治疗的比例:环境:英国威尔士西部农村地区的社区门诊:开发:由两名经验丰富的非医疗处方药剂师提供门诊服务,其中一名药剂师还具有心脏病学诊断资格:实施:根据钠尿肽水平,对转诊的疑似心房颤动患者进行风险分级,以进行紧急(转诊后 14 天内)或常规(42 天内)复查。患者到诊所接受评估,包括体格检查、心电图和超声心动图检查。射血分数降低的心房颤动患者将接受药物治疗,并转诊至药剂师主导的 GDMT 随访门诊:对 100 名患者进行了抽样评估(50 名来自原有服务,50 名来自新服务)。从转诊到确诊的中位时间从61天(IQR 47-115)缩短至16天(IQR 10.5-27.5)(急诊)和19天(IQR 11.5-33)(常规)。确诊后首次就诊的中位时间从 54 天(IQR 36-60.5)缩短至 14 天(IQR 9.75-28.75)(P 值 结论):该药剂师高频诊断诊所和药物优化诊所改善了农村医疗环境中的诊断时间、首次专家复查时间和实现 GDMT 优化的患者比例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.10
自引率
8.30%
发文量
131
审稿时长
4-8 weeks
期刊介绍: The International Journal of Clinical Pharmacy (IJCP) offers a platform for articles on research in Clinical Pharmacy, Pharmaceutical Care and related practice-oriented subjects in the pharmaceutical sciences. IJCP is a bi-monthly, international, peer-reviewed journal that publishes original research data, new ideas and discussions on pharmacotherapy and outcome research, clinical pharmacy, pharmacoepidemiology, pharmacoeconomics, the clinical use of medicines, medical devices and laboratory tests, information on medicines and medical devices information, pharmacy services research, medication management, other clinical aspects of pharmacy. IJCP publishes original Research articles, Review articles , Short research reports, Commentaries, book reviews, and Letters to the Editor. International Journal of Clinical Pharmacy is affiliated with the European Society of Clinical Pharmacy (ESCP). ESCP promotes practice and research in Clinical Pharmacy, especially in Europe. The general aim of the society is to advance education, practice and research in Clinical Pharmacy . Until 2010 the journal was called Pharmacy World & Science.
期刊最新文献
Exploring the impact of baseline platelet count on linezolid-induced thrombocytopenia: a retrospective single-center observation study. Sentiment analysis in medication adherence: using ruled-based and artificial intelligence-driven algorithms to understand patient medication experiences. Translation and validation of the CLEO tool in Vietnamese to assess the significance of pharmacist interventions. Association of polypharmacy with clinical outcomes and healthcare utilization in older adults with cardiometabolic diseases: a retrospective cohort study. Correction: Development and validation of a Medication Adherence Universal Questionnaire: the MAUQ.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1